ADME, how a drug is absorbed, distributed, metabolized, and excreted
Definition
ADME (Absorption, Distribution, Metabolism, Excretion) describes the pharmacokinetic profile of a drug compound within an organism. Absorption refers to how a drug enters the bloodstream from its administration site. Distribution describes how the drug travels through body tissues and organs. Metabolism covers enzymatic biotransformation, primarily in the liver, that converts drugs into metabolites. Excretion eliminates the drug and its metabolites, mainly through urine or bile. Together, ADME properties determine drug bioavailability, half-life, dosing frequency, and potential toxicity — making ADME optimisation a critical phase in drug discovery and development pipelines.
In Practice
Drug Discovery is central to molecular biology research and clinical applications. Key use cases include:
- Predicting drug absorption and bioavailability in early-stage drug development
- Evaluating tissue distribution and protein binding of candidate compounds
- Assessing metabolic stability and identifying major metabolic pathways
- Characterizing elimination half-life and clearance rates in preclinical models
- Optimising lead compounds for improved pharmacokinetic properties
- Informing dose selection and dosing intervals for clinical trials
Frequently Asked Questions
Why is ADME important in drug discovery?
ADME profiling is critical because poor pharmacokinetics account for approximately 40% of drug candidate failures in clinical development. Understanding absorption, distribution, metabolism, and excretion early in discovery helps select compounds with favourable drug-like properties, reducing late-stage attrition and development costs.
What is the difference between ADME and pharmacokinetics?
ADME describes the four processes that determine drug disposition, while pharmacokinetics (PK) is the quantitative study of these processes over time. PK parameters like Cmax, Tmax, half-life, AUC, and clearance are derived from measuring drug concentrations in biological samples at multiple time points following administration.
How are ADME properties predicted computationally?
Computational ADME prediction uses quantitative structure-activity relationship (QSAR) models trained on experimental data to predict properties like Caco-2 permeability, human intestinal absorption, plasma protein binding, CYP450 inhibition, and P-glycoprotein substrate status. Lipinski's Rule of Five provides a simple filter for oral bioavailability prediction.
VigyanLLM Application
VigyanLLM supports researchers working with adme through its integrated suite of bioinformatics tools. The platform provides automated primer design with 22-step biophysical validation, BLAST sequence search for specificity checking, and a comprehensive PCR analysis module. Researchers can design, validate, and order primers for adme applications using the VigyanLLM pipeline, with audit-ready reporting for publication and compliance.